RSS Feeds


LTS Lohmann Therapie-Systeme AG

LTS Lohmann Therapie-Systeme AG
LTS Lohmann Therapie-Systeme AG is a world class developer and manufacturer of transdermal (TTS) and oral thin film (OTF) drug delivery systems and adhesive laminates.

The company in detail


LTS is a leader in the transdermal area with a successful and proven track record. Throughout the last 30 years, LTS has developed more than 20 products which have been successfully commercialized by our pharmaceutical partners.

As a manufacturing and development company of drug delivery systems, LTS is not involved in marketing and distribution of pharmaceutical products.

LTS is open and free to cooperate with its partners based on their requirements. Typical ways of cooperation are:
• Development of transdermal systems or flat film-forming dosage forms for oral application in joint cooperation with pharmaceutical partners. As a result of this cooperation the distribution and marketing rights belong exclusively to the pharmaceutical company, and LTS retains the manufacturing rights.
• Own-funded developments are licensed to other companies retaining the rights of manufacturing.
• Toll manufacturing of patches and oral film forms developed by third parties.

As full service company LTS has the capabilities and facilities to do all facets of product development from feasibility of final production;

LTS is worldwide the only manufacturer of transdermal systems and oral film forms who has FDA-approved production plants with identical equipment on two continents to serve customers. Its state of the art facilities are in GMP compliance and actively producing FDA approved products. The production sites have a capacity of several billion systems per year. Experience from having delivered large commercial quality of patches and oral film forms in the last 30 years makes LTS unique in this field.

LTS has patented various transdermal patch technologies including drug in adhesive matrix systems, multilayered matrix systems as well as different types of reservoir systems (liquid and semi solid reservoir). LTS has prior experience and in-house technical knowledge which allow the utilization of drug incorporation to all types of adhesives including: silicones, PIB's and acrylics.

Moreover, LTS has developed patented technologies for flat film-forming dosage forms for oral drug delivery ranging from flash-release wafer systems to mucoadhesive buccal patch systems.

In addition, LTS offers service for clinical evaluation through a wholly owned CRO, located in Germany.


Capsaicin, the active ingredient found in red-hot peppers, is used mainly for the relief of chronic pain of rheumatoid arthritis and osteoarthritis More
Currently, LTS has two matrix formulation under development varying in their manufacturing process More
The development of a transdermal therapeutic system offers the advantages of constant plasma levels i.e. avoiding of plasma peaks and providing of therapeutic plasma level during the early morning hours More

Contact details

Klaudia Haczkiewicz
Head of Business Development

Contact directly

Full contact list

Head office

LTS Lohmann Therapie-Systeme AG
Lohmannstr. 2

Company figures

Formed: 1984

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2014 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us